Cargando…
Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay
Candida albicans, the most common human pathogenic fungus, can establish a persistent lethal infection in the intestine of the microscopic nematode Caenorhabditis elegans. The C. elegans–C. albicans infection model was previously adapted to screen for antifungal compounds. Modifications to this scre...
Autores principales: | Okoli, Ikechukwu, Coleman, Jeffrey J., Tempakakis, Emmanouil, An, W. Frank, Holson, Edward, Wagner, Florence, Conery, Annie L., Larkins-Ford, Jonah, Wu, Gang, Stern, Andy, Ausubel, Frederick M., Mylonakis, Eleftherios |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737148/ https://www.ncbi.nlm.nih.gov/pubmed/19750012 http://dx.doi.org/10.1371/journal.pone.0007025 |
Ejemplares similares
-
Correction: Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay
por: Okoli, Ikechukwu, et al.
Publicado: (2010) -
Candida albicans Infection of Caenorhabditis elegans Induces Antifungal Immune Defenses
por: Pukkila-Worley, Read, et al.
Publicado: (2011) -
Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2014) -
Lipid signalling couples translational surveillance to systemic detoxification in Caenorhabditis elegans
por: Govindan, J. Amaranath, et al.
Publicado: (2015) -
Antifungal Activity of Microbial Secondary Metabolites
por: Coleman, Jeffrey J., et al.
Publicado: (2011)